Takeda Pharmaceutical »

Rani Therapeutics Hldgs shares owned by Takeda Pharmaceutical

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Takeda Pharmaceutical from 13F filings

Historical chart of Takeda Pharmaceutical investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Takeda Pharmaceutical consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Takeda Pharmaceutical

Quarter filed Position value Share count Share price at filing
2025-09-30 $102k 203k 0.50
2025-06-30 $104k 203k 0.51
2025-03-31 $256k 203k 1.26

More positions owned by Takeda Pharmaceutical

Ovid Therapeutics (OVID)
Equillium (EQ)
Xilio Therapeutics (XLO)
Shattuck Labs (STTK)
Lyell Immunopharma
American Well Corp-class A (AMWL)
Rani Therapeutics Hldgs (RANI)
D Fluidigm Corp Del (LAB)

View all positions for Takeda Pharmaceutical

Top funds holding Rani Therapeutics Hldgs

Vanguard Group
Nan Fung Group Holdings
Citadel Advisors
United Services Automobile Association
Geode Capital Management
Kestra Private Wealth Services
Takeda Pharmaceutical
CWA Asset Management
BlackRock
Hrt Financial
Northern Trust
UBS Group
Marc Lasry
State Street Corporation
Luther King Capital Management Corporation

View all funds holding Rani Therapeutics Hldgs